I''ll chime as a long time holder of shares under
Post# of 148165
Otherwise I agree with all of TechGuru's reasons for continuing to hold, well put as usual. I recall hearing that CYDY has been de-risked since it was at 50 cents on its way down from 75 cents, cuz they had made such big strides in the HIV studies...and an approval could come soon. It was just working too well. Once approved, it will immediately be accepted and an easy sell because HIV patients are a "close crowd" and talk and research and share and together and will all know about it right away. Turned out to be a great time to keep buying.
I've since come to be concerned over the FDA's apparent resistance to us, likely pushed by BP. I'm truly hoping that is not the case, and not sure we can control that or do much about it IF that is the case...except continue to prove the science. And I still believe that will be the case. Very much looking forward to the CD12 results VERY SOON now. Think how close that event is. And what really good...or GREAT results will mean. For possibly finally providing an approval for a life-saving and economy-saving treatment, and for the share price. It's close folks.
And that is just for Covid....
To The Moon Alice